Fig. 4From: The HO-1-expressing bone mesenchymal stem cells protects intestine from ischemia and reperfusion injuryBMSC/HO-1 attenuated production of ROS, IL-6 and TNF-α (n = 6). a ROS production; b TNF-α production; c IL-6 production in intestine and serum. Levels of ROS in intestine at 24 h of reperfusion were significantly higher than those in sham group and decreased after treatment of BMSC/HO-1. Moreover, IL-6 and TNF-α were significantly lower in BMSC/HO-1 group at 24 h compared to those in I/R group. ** p < 0.01 vs. Sham; # p < 0.05 and ## p < 0.01 vs. I/R; + p < 0.05 and ++ p < 0.01 vs. BMSCBack to article page